vs

Side-by-side financial comparison of Cardinal Health (CAH) and Caterpillar Inc. (CAT). Click either name above to swap in a different company.

Caterpillar Inc. is the larger business by last-quarter revenue ($85.0B vs $60.9B, roughly 1.4× Cardinal Health). On growth, Cardinal Health posted the faster year-over-year revenue change (11.0% vs -17.7%). Over the past eight quarters, Caterpillar Inc.'s revenue compounded faster (125.7% CAGR vs 5.3%).

Cardinal Health, Inc. is an American multinational health care services company, and the 15th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical product, including gloves, surgical apparel, and fluid management products.

Caterpillar Inc. is an American construction, mining, and other engineering equipment manufacturer. The company is the world's largest manufacturer of construction equipment. In 2018, Caterpillar was ranked number 73 on the Fortune 500 list and number 265 on the Global Fortune 500 list. Caterpillar stock is a component of the Dow Jones Industrial Average.

CAH vs CAT — Head-to-Head

Bigger by revenue
CAT
CAT
1.4× larger
CAT
$85.0B
$60.9B
CAH
Growing faster (revenue YoY)
CAH
CAH
+28.7% gap
CAH
11.0%
-17.7%
CAT
Faster 2-yr revenue CAGR
CAT
CAT
Annualised
CAT
125.7%
5.3%
CAH

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
CAH
CAH
CAT
CAT
Revenue
$60.9B
$85.0B
Net Profit
$380.0M
Gross Margin
89.5%
Operating Margin
0.8%
3.0%
Net Margin
0.6%
Revenue YoY
11.0%
-17.7%
Net Profit YoY
-21.1%
EPS (diluted)
$1.69
$4.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CAH
CAH
CAT
CAT
Q1 26
$60.9B
$85.0B
Q4 25
$65.6B
$19.1B
Q3 25
$17.6B
Q2 25
$60.2B
$16.6B
Q1 25
$54.9B
$14.2B
Q4 24
$55.3B
$16.2B
Q3 24
$52.3B
$16.1B
Q2 24
$59.7B
$16.7B
Net Profit
CAH
CAH
CAT
CAT
Q1 26
$380.0M
Q4 25
$467.0M
$2.4B
Q3 25
$2.3B
Q2 25
$239.0M
$2.2B
Q1 25
$506.0M
$2.0B
Q4 24
$400.0M
$2.8B
Q3 24
$416.0M
$2.5B
Q2 24
$236.0M
$2.7B
Gross Margin
CAH
CAH
CAT
CAT
Q1 26
89.5%
Q4 25
3.7%
30.5%
Q3 25
33.8%
Q2 25
3.7%
34.8%
Q1 25
3.9%
37.1%
Q4 24
3.5%
36.3%
Q3 24
3.6%
37.5%
Q2 24
3.1%
39.2%
Operating Margin
CAH
CAH
CAT
CAT
Q1 26
0.8%
3.0%
Q4 25
1.1%
13.9%
Q3 25
17.3%
Q2 25
0.7%
17.3%
Q1 25
1.3%
18.1%
Q4 24
1.0%
18.0%
Q3 24
1.1%
19.5%
Q2 24
0.7%
20.9%
Net Margin
CAH
CAH
CAT
CAT
Q1 26
0.6%
Q4 25
0.7%
12.5%
Q3 25
13.0%
Q2 25
0.4%
13.2%
Q1 25
0.9%
14.1%
Q4 24
0.7%
17.2%
Q3 24
0.8%
15.3%
Q2 24
0.4%
16.1%
EPS (diluted)
CAH
CAH
CAT
CAT
Q1 26
$1.69
$4.20
Q4 25
$5.11
Q3 25
$4.88
Q2 25
$4.62
Q1 25
$4.20
Q4 24
$5.76
Q3 24
$1.70
$5.06
Q2 24
$0.86
$5.48

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CAH
CAH
CAT
CAT
Cash + ST InvestmentsLiquidity on hand
$3.9B
$10.0M
Total DebtLower is stronger
$0
Stockholders' EquityBook value
$21.3M
Total Assets
$56.7B
$98.6M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CAH
CAH
CAT
CAT
Q1 26
$3.9B
$10.0M
Q4 25
$2.8B
$10.0B
Q3 25
$7.5B
Q2 25
$3.9B
$5.4B
Q1 25
$3.3B
$3.6B
Q4 24
$3.8B
$6.9B
Q3 24
$2.9B
$5.6B
Q2 24
$5.3B
$4.3B
Total Debt
CAH
CAH
CAT
CAT
Q1 26
$0
Q4 25
$8.3B
Q3 25
Q2 25
$8.0B
Q1 25
$7.1B
Q4 24
$7.1B
Q3 24
$4.2B
Q2 24
$4.7B
Stockholders' Equity
CAH
CAH
CAT
CAT
Q1 26
$21.3M
Q4 25
$-2.9B
$21.3B
Q3 25
$20.7B
Q2 25
$-2.8B
$18.7B
Q1 25
$-2.9B
$18.1B
Q4 24
$-3.0B
$19.5B
Q3 24
$-3.3B
$19.4B
Q2 24
$-3.2B
$17.1B
Total Assets
CAH
CAH
CAT
CAT
Q1 26
$56.7B
$98.6M
Q4 25
$58.1B
$98.6B
Q3 25
$93.7B
Q2 25
$53.1B
$90.3B
Q1 25
$49.9B
$85.0B
Q4 24
$47.0B
$87.8B
Q3 24
$43.1B
$86.3B
Q2 24
$45.1B
$83.3B
Debt / Equity
CAH
CAH
CAT
CAT
Q1 26
0.00×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CAH
CAH
CAT
CAT
Operating Cash FlowLast quarter
$1.8B
Free Cash FlowOCF − Capex
$1.7B
FCF MarginFCF / Revenue
2.8%
Capex IntensityCapex / Revenue
835.3%
Cash ConversionOCF / Net Profit
4.80×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CAH
CAH
CAT
CAT
Q1 26
$1.8B
Q4 25
$3.6B
Q3 25
$3.7B
Q2 25
$1.5B
$3.1B
Q1 25
$2.9B
$1.3B
Q4 24
$-400.0M
$3.4B
Q3 24
$-1.6B
$3.6B
Q2 24
$2.1B
$3.0B
Free Cash Flow
CAH
CAH
CAT
CAT
Q1 26
$1.7B
Q4 25
$2.7B
Q3 25
$3.1B
Q2 25
$1.3B
$2.6B
Q1 25
$2.8B
$579.0M
Q4 24
$-499.0M
$2.7B
Q3 24
$-1.7B
$3.1B
Q2 24
$1.9B
$2.7B
FCF Margin
CAH
CAH
CAT
CAT
Q1 26
2.8%
Q4 25
14.1%
Q3 25
17.5%
Q2 25
2.2%
15.5%
Q1 25
5.1%
4.1%
Q4 24
-0.9%
16.6%
Q3 24
-3.3%
19.4%
Q2 24
3.2%
16.1%
Capex Intensity
CAH
CAH
CAT
CAT
Q1 26
835.3%
Q4 25
4.7%
Q3 25
3.7%
Q2 25
0.4%
3.3%
Q1 25
0.2%
5.0%
Q4 24
0.2%
4.3%
Q3 24
0.2%
2.8%
Q2 24
0.3%
2.0%
Cash Conversion
CAH
CAH
CAT
CAT
Q1 26
4.80×
Q4 25
1.50×
Q3 25
1.63×
Q2 25
6.39×
1.43×
Q1 25
5.76×
0.64×
Q4 24
-1.00×
1.22×
Q3 24
-3.96×
1.45×
Q2 24
8.80×
1.13×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons